상위피인용논문
Hee-Gyeong Yi a 1, Yeong-Jin Choi b 1, Kyung Shin Kang c, Jung Min Hong c, Ruby Gupta Pati a, Moon Nyeo Park a, In Kyong Shim d, Chan Mi Lee d, Song Cheol Kim d e, Dong-Woo Cho a
aDepartment of Mechanical Engineering, Pohang University of Science and Technology (POSTECH), Pohang, Kyungbuk, Republic of Korea
bDivision of Integrative Biosciences and Biotechnology, POSTECH, Pohang, Kyungbuk, Republic of Korea
cDepartment of Anatomy & Cell Biology, Indiana University School of Medicine, Indianapolis, IN, USA
dBiomedical Engineering Research Center, Asan Institute for Life Sciences, Asan Medical Center, Seoul, Republic of Korea
eDepartment of Surgery, University of Ulsan Colleague of Medicine & Asan Medical Center, Seoul, Republic of Korea
1These authors contributed equally to this work.
Corresponding author: correspondence to Song Cheol Kim or Dong-Woo Cho
Abstract
Since recurrence and metastasis of pancreatic cancer has a worse prognosis, chemotherapy has been typically performed to attack the remained malignant cells after resection. However, it is difficult to achieve the therapeutic concentration at the tumor site with systemic chemotherapy. Numerous local drug delivery systems have been studied to overcome the shortcomings of systemic delivery. However, because most systems involve dissolution of the drug within the carrier, the concentration of the drug is limited to the saturation solubility, and consequently cannot reach the sufficient drug dose. Therefore, we hypothesized that 3D printing of a biodegradable patch incorporated with a high drug concentration would provide a versatile shape to be administered at the exact tumor site as well as an appropriate therapeutic drug concentration with a controlled release. Here, we introduce the 3D-printed patches composed of a blend of poly(lactide-co-glycolide), polycaprolactone, and 5-fluorouracil for delivering the anti-cancer drug in a prolonged controlled manner and therapeutic dose. 3D printing technology can manipulate the geometry of the patch and the drug release kinetics. The patches were flexible, and released the drug over four weeks, and thereby suppressed growth of the subcutaneous pancreatic cancer xenografts in mice with minimized side effects. Our approach reveals that 3D printing of bioabsorbable implants containing anti-cancer drugs could be a powerful method for an effective local delivery of chemotherapeutic agents to treatment of cancers.
논문정보
관련 링크
연구자 키워드
관련분야 연구자보기
소속기관 논문보기
관련분야 논문보기